Description: GSK3532795 HCl, formerly known as BMS955176, is a potent, orally bioavailable, second-generation HIV-1 maturation inhibitor (MI) that advanced through phase IIb clinical trials. GSK3532795 combines broad coverage of polymorphic viruses (EC50<15 nM toward a panel of common polymorphisms representative of 96.5% HIV-1 subtype B virus) with a favorable pharmacokinetic profile in preclinical species.

References: J Med Chem. 2018 Aug 23;61(16):7289-7313; PLoS One. 2018 Oct 23;13(10):e0205368.

Related CAS #: 1392312-45-6 (free base) 2097784-79-5 (TFA) 2023808-13-9 (HCl) 2023798-97-0 (HCl hydrate) 2097784-79-5 (oxalate)

纯度：≥98%

CAS：2023808-13-9